Bavli Ia L
Vopr Onkol. 1980;26(5):13-5.
The analysis of the course and issues of the disease in 1424 patients with operable cancer of the mammary gland indicated that using of the postoperative chemotherapy increases a 5-year survival without recurrences and metastases, on an average, by 10%, while in early tumors (without regional metastases)--by 15-20%. Moreover, in patients subjected to chemotherapy distant metastases appear in later terms than in those without it.
对1424例可手术乳腺癌患者的病程及相关问题分析表明，术后化疗可使无复发和转移的5年生存率平均提高10%，而早期肿瘤（无区域转移）患者的这一比例提高15% - 20%。此外，接受化疗的患者远处转移出现的时间比未接受化疗的患者更晚。
